AbbVie vs Johnson & Johnson: which one returned more?

In short — over ~10 years, $1,000 invested in AbbVie would be worth $4,248 vs $2,472 for Johnson & Johnson → AbbVie wins. Average annual return: AbbVie +16%/yr, Johnson & Johnson +9%/yr. Price performance, excluding dividends.

$1,000 invested in AbbVie or Johnson & Johnson

Investment ↕	AbbVie i ↕	Johnson & Johnson i ↕	Winner ↕
5 years ago	$2,348	$1,614	🟢 AbbVie
10 years ago	$4,248	$2,472	🟢 AbbVie

Return by year: AbbVie vs Johnson & Johnson

Year ▼	AbbVie i ↕	Johnson & Johnson i ↕	Winner ↕
2026	+10%	+23%	🔵 Johnson & Johnson
2025	+29%	+43%	🔵 Johnson & Johnson
2024	+15%	-8%	🟢 AbbVie
2023	-4%	-11%	🟢 AbbVie
2022	+19%	+3%	🟢 AbbVie
2021	+26%	+9%	🟢 AbbVie
2020	+21%	+8%	🟢 AbbVie
2019	-4%	+13%	🔵 Johnson & Johnson
2018	-5%	-8%	🟢 AbbVie
2017	+54%	+21%	🟢 AbbVie
2016	+6%	+12%	🔵 Johnson & Johnson

⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

Frequently asked questions

AbbVie or Johnson & Johnson: which returned more over 10 years?

Over ~10 years, $1,000 invested in AbbVie is worth $4,248 vs $2,472 for Johnson & Johnson. AbbVie wins over this period (price performance, excluding dividends). Past performance does not predict the future.

Is this comparison investment advice?

No. It is a factual comparison of past performance (real Yahoo Finance prices), for educational purposes. Diversify and adapt to your horizon and risk tolerance.

What is JPI Invest?

JPI Invest ranks financial analysts on their real results (targets replayed against real prices, backtested over 11 years) and derives stock selections. Beyond asset comparisons, explore the interactive table, the method and the best stocks to buy.